First photoactive drug for pain treatments
from University of Barcelona via ScienceDaily
A team of the Institute of Neurosciences of the University of Barcelona has participated in the design of the first light-activated drug — the JF-NP-26 — for the treatment of pain, according to a research with animal models published in the journal eLife. In this new optopharmacology proposal, a drug with a known action mechanism (for example an analgesic) is chemically modified to make it photosensitive and inactive. This drug is activated when receiving light — using an optical fiber — of a suitable wave length and with an exact precision on the target tissue (brain, skin, articulations, etc.).
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063